Skip to content

Checked

Class IIDrug recallOngoing

Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol recall

Recalled by AEQUITA PHARMACY of Kirkland, WA · FDA report 08/13/2025

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
07/18/2025
Distribution
See below

Reason for recall

Lack of Processing Controls.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Lot and code info
All Lots within expiry.
Quantity
190 vials
Recall number
D-0563-2025
Event ID
97292
Initiated by
Voluntary: Firm initiated

Where it was distributed

MA

Recall timeline

  1. 07/18/2025Firm started the recall
  2. 08/01/2025FDA classified it as Class II
  3. 08/13/2025Published in the FDA enforcement report

All products in this recall

13 products under event 97292

Frequently asked questions

Why was Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol recalled?
Lack of Processing Controls.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 08/13/2025 · Do not rely on openFDA to make decisions regarding medical care